The emerging therapy of the medication represents a exciting advance in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide079117.designertoblog.com/73557695/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment